Science Explorer Interactive view Map
Company · Mississauga · Canada

GlaxoSmithKline (Canada)

gsk.ca/englishROR OpenAlex
World rank, all time
#29,594
of 42,892
Rank in Canada
#635
of 896
Research works
126
▼ 20% vs 2013–17
Citations
4.2k
33.3 per fractional work
Top-10% rate
15.1%
record average 16.5%
Open access
44%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.12× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.91× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 4.24× its world share, 1 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 0.61× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.77× its world share, 0 worksChemistryEngineering: 0.04× its world share, 0 worksEngineeringEnvironmental Science: 0.10× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.06× its world share, 0 worksMaterials ScienceMathematics: 0.22× its world share, 0 worksMathematicsMedicine: 4.28× its world share, 26 worksMedicineDecision Sciences: 0.22× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 1.82× its world share, 1 worksEconomics, Econometr…Social Sciences: 0.08× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 4.3×. Every wedge is a field page.

Who are the top researchers at GlaxoSmithKline (Canada)?

Ranked on the composite score, Nigel S. B. Rawson lead among researchers whose main affiliation is GlaxoSmithKline (Canada).

  1. 1 Nigel S. B. Rawson Canada · #1,180,872 worldwide 37 citations · 16 works
All ranked researchers at GlaxoSmithKline (Canada)

Which keywords describe research at GlaxoSmithKline (Canada)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Inflammation, Treatment, Antiretroviral Therapy, Quality of Life, Asthma, Eosinophilia and Diagnosis.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 30 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 30 words, with their numbers
  1. Epidemiology7▲ 5.4×18 topics
  2. Inflammation4▲ 7.0×9 topics
  3. Treatment4▲ 11×11 topics
  4. Antiretroviral Therapy3▲ 61×4 topics
  5. Quality of Life3▲ 6.7×10 topics
  6. Asthma3▲ 88×2 topics
  7. Eosinophilia3▲ 157×2 topics
  8. Diagnosis2▲ 8.7×10 topics
  9. Management2▲ 10×8 topics
  10. Genetics2▲ 11×3 topics
  11. Immunology2▲ 68×2 topics
  12. Allergic Diseases2▲ 120×1 topic
  13. Cardiovascular Disease2▲ 6.2×5 topics
  14. Eosinophils2▲ 120×1 topic
  15. Classification2▲ 14×2 topics
  16. Immune Response2▲ 11×7 topics
  17. Fusion Genes2▲ 268×1 topic
  18. Hypereosinophilic Syndrome2▲ 268×1 topic
  19. HIV Infection2▲ 56×2 topics
  20. Vaccine2▲ 14×5 topics
  21. Chronic Kidney Disease1▲ 18×2 topics
  22. Adverse Effects1▲ 84×2 topics
  23. Pathogenesis1▲ 7.6×6 topics
  24. Anemia1▲ 38×2 topics
  25. Drug Resistance1▲ 13×1 topic
  26. Immunosuppressive Therapy1▲ 19×4 topics
  27. Integrase Inhibitors1▲ 174×1 topic
  28. Chemotherapy1▲ 4.7×9 topics
  29. Children1▲ 14×2 topics
  30. Clinical Trials1▲ 4.9×6 topics

Which research topics does GlaxoSmithKline (Canada) publish most on?

By volume in 2022–2025: Asthma and respiratory diseases, Eosinophilic Disorders and Syndromes, HIV/AIDS drug development and treatment and Eosinophilic Esophagitis.

Asthma and respiratory diseases: 2 fractional worksEosinophilic Disorders and Syndromes: 2 fractional worksHIV/AIDS drug development and treatment: 1 fractional worksEosinophilic Esophagitis: 1 fractional worksVasculitis and related conditions: 1 fractional worksHIV Research and Treatment: 1 fractional worksLiver Diseases and Immun…1Liver Diseases and Immunity: 1 fractional worksErythropoietin and Anemia Treatment: 1 fractional worksHIV-related health complications and treatments: 1 fractional worksHerpesvirus Infections and Treatments: 1 fractional works
PhysiologyRheumatologyInfectious DiseasesSurgery6 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Asthma and respiratory diseases Physiology 2 works
  2. 2 Eosinophilic Disorders and Syndromes Rheumatology 2 works
  3. 3 HIV/AIDS drug development and treatment Infectious Diseases 1 works
  4. 4 Eosinophilic Esophagitis Surgery 1 works
  5. 5 Vasculitis and related conditions Pulmonary and Respiratory Medicine 1 works
  6. 6 HIV Research and Treatment Virology 1 works
  7. 7 Liver Diseases and Immunity Hepatology 1 works
  8. 8 Erythropoietin and Anemia Treatment Hematology 1 works
  9. 9 HIV-related health complications and treatments Emergency Medicine 1 works
  10. 10 Herpesvirus Infections and Treatments Epidemiology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available44.0%not open56.0%

World: 28% of research is openly available.

with international co-authors60.2%domestic only39.8%

World: 19% is written across borders.

How has GlaxoSmithKline (Canada)'s research output changed?

Output in 2018–2022 was 20% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Mississauga

All research institutions in Mississauga

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.